Skip to main content

Advertisement

SpringerLink
Log in

Breast and colorectal cancer survivors’ knowledge about their diagnosis and treatment

  • Published:
Journal of Cancer Survivorship Aims and scope Submit manuscript

Abstract

Introduction

Aspects of a personal cancer history can have implications for future decisions regarding screening, diagnosis, and treatment. Clinicians must sometimes rely on patients’ self-report of their medical history. This study assessed knowledge of details of cancer diagnosis and treatment among breast and colorectal cancer survivors.

Methods

Written surveys were completed by 480 breast cancer survivors and 366 colorectal cancer survivors diagnosed between 1999 and 2008 at a large cancer center in the Minneapolis, MN, area (81% response rate). Responses were compared with cancer registry and medical records.

Results

Forty percent of breast cancer survivors and 65% of colorectal cancer survivors were unable to identify their stage of disease. Seven percent of breast cancer survivors and 21% of colorectal cancer survivors in whom regional nodes were examined did not know whether they had positive nodes. Accuracy of knowledge of estrogen and progesterone status among breast cancer survivors was 58% and 39%, respectively. Of breast cancer survivors treated with doxorubicin, 43% correctly identified it as a drug they had received. Their accuracy of identification of receipt of tamoxifen or specific aromatase inhibitors was >90%. Of colorectal cancer survivors treated with oxaliplatin, 52% correctly identified it as a drug they had received. Accuracy on many items decreased with patient age.

Conclusions

This study identifies several gaps in adult cancer survivors’ knowledge of details of their diagnosis and treatment that have implications for follow-up care.

Implications for cancer survivors

Provision of written treatment summaries to cancer survivors could help them obtain appropriate patient-centered long-term follow-up care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al., editors. SEER Cancer Statistics Review. 1975–2007. Bethesda, MD, National Cancer Institute. http://seer.cancer.gov/csr/1975_2007/.

  2. Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, et al. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol. 2007;25:3991–4008.

    Article  PubMed  CAS  Google Scholar 

  3. Grothey A. Clinical management of oxaliplatin-associated neurotoxicity. Clin Colorectal Cancer. 2005;5:S38–46.

    Article  PubMed  CAS  Google Scholar 

  4. Eastell R, Adams JE, Coleman RE, Howell A, Hannon RA, Cuzick J, et al. Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230. J Clin Oncol. 2008;26:1051–7.

    Article  PubMed  CAS  Google Scholar 

  5. Perez EA, Josse RG, Pritchard KI, Ingle JN, Martino S, Findlay BP, et al. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17. J Clin Oncol. 2006;24:3629–35.

    Article  PubMed  CAS  Google Scholar 

  6. Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM, et al. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst. 1994;86:527–37.

    Article  PubMed  CAS  Google Scholar 

  7. Tubiana M. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncology. 2009;91:4–15.

    Article  Google Scholar 

  8. Mosen DM, Schmittdiel J, Hibbard J, Sabel D, Remmers C, Bellows J. Is patient activation associated with outcomes of care for adults with chronic conditions? J Ambulatory Care Manage. 2007;30:21–9.

    PubMed  Google Scholar 

  9. Hewitt M, Greenfield S, Stovall E, editors. From cancer patient to cancer survivor: lost in transition. Washington: Institute of Medicine, National Academies Press; 2006.

    Google Scholar 

  10. American Society of Clinical Oncology. Chemotherapy treatment plan and summary. http://www.asco.org/treatmentsummary. Accessed 2 May 2011.

  11. Lance Armstrong Foundation. Livestrong Care Plan. http://www.livestrongcareplan.org. Accessed 2 May 2011.

  12. Desai MM, Bruce ML, Desai RA, Druss BG. Validity of self-reported cancer history: a comparison of health interview data and cancer registry records. Am J Epidemiol. 2001;153:299–306.

    Article  PubMed  CAS  Google Scholar 

  13. Paganini-Hill A, Chao A. Accuracy of recall of hip fracture, heart attack, and cancer: a comparison of postal survey data and medical records. Am J Epidemiol. 1993;138:101–6.

    PubMed  CAS  Google Scholar 

  14. Schrijvers CTM, Stronks K, van de Mheen DH, Coebergh JW, Mackenbach JP. Validation of cancer prevalence data from a postal survey by comparison with cancer registry records. Am J Epidemiol. 1994;139:408–14.

    PubMed  CAS  Google Scholar 

  15. Abraham L, Geller BM, Yankaskas BC, Bowles EJA, Karliner LS, Taplin SH, et al. Accuracy of self-reported breast cancer among women undergoing mammography. Breast Cancer Res Treat. 2009;118:583–92.

    Article  PubMed  CAS  Google Scholar 

  16. Bergmann MM, Calle EE, Mervis CA, Miracle-McMahill HL, Thun MJ, Heath CW. Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries. Am J Epidemiol. 1998;147:556–62.

    PubMed  CAS  Google Scholar 

  17. Manjer J, Merlo J, Berglund G. Validity of self-reported information on cancer: determinants of under and over-reporting. Eur J Epidemiol. 2004;19:239–47.

    Article  PubMed  Google Scholar 

  18. Parikh-Patel A, Allen M, Wright WE, and the California Teachers Study Steering Committee. Validation of self-reported cancers in the California Teachers Study. Am J Epidemiol. 2003;157:539–45.

    Article  PubMed  Google Scholar 

  19. Nord C, Mykletun A, Fossa SD. Cancer patients’ awareness about their diagnosis: a population-based study. J Public Health Med. 2003;25:313–7.

    Article  PubMed  CAS  Google Scholar 

  20. Kadan-Lottick NS, Robison LL, Gurney JG, Neglia JP, Yasui Y, Hayashi R, et al. Childhood cancer survivors’ knowledge about their past diagnosis and treatment: Childhood Cancer Survivor Study. JAMA. 2002;287:1832–9.

    Article  PubMed  Google Scholar 

  21. Bashore L. Childhood and adolescent cancer survivors’ knowledge of their disease and effects of treatment. J Ped Oncol Nurs. 2004;21:98–102.

    Article  Google Scholar 

  22. Byrne J, Lewis MES, Halamek L, Connelly RR, Mulvihill JJ. Childhood cancer survivors’ knowledge of their diagnosis and treatment. Ann Intern Med. 1989;110:400–3.

    PubMed  CAS  Google Scholar 

  23. Royak-Schaler R, Gardner LD, Shardell M, Zhan M, Passmore SR, Gadalla SM, et al. Evidence-based care for breast cancer survivors: communicating the Institute of Medicine guidelines in medical practice. Patient Educ Couns. 2009;77:413–20.

    Article  PubMed  Google Scholar 

  24. Malin JL, Kahn KL, Adams J, Kwan L, Laouri M, Ganz PA. Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst. 2002;94:835–44.

    Article  PubMed  Google Scholar 

  25. Cress RD, Zaslavsky AM, West DW, Wolf RE, Felter MC, Ayanian JZ. Completeness of information on adjuvant therapies for colorectal cancer in population-based cancer registries. Med Care. 2003;41:1006–12.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This project was funded by Park Nicollet Foundation. We thank Susan Koering for her assistance with registry data, Dr. DeAnn Lazovich for helpful comments on the manuscript, and Melissa McMahon for clerical assistance.

Author information

Authors and Affiliations

  1. Oncology Research Department, Park Nicollet Institute, 3931 Louisiana Avenue, FRCC, 1st Floor, St. Louis Park, Minneapolis, MN, 55426, USA

    Mary Jo Nissen, Michaela L. Tsai & Karen K. Swenson

  2. Division of Hematology/Oncology/Transplantation, University of Minnesota, Minneapolis, MN, USA

    Anne H. Blaes

Authors
  1. Mary Jo Nissen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michaela L. Tsai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anne H. Blaes
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Karen K. Swenson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mary Jo Nissen.

Appendix: Breast and colorectal cancer history questionnaires

Appendix: Breast and colorectal cancer history questionnaires

BREAST CANCER HISTORY QUESTIONNAIRE

figure a

COLORECTAL CANCER HISTORY QUESTIONNAIRE

figure b

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nissen, M.J., Tsai, M.L., Blaes, A.H. et al. Breast and colorectal cancer survivors’ knowledge about their diagnosis and treatment. J Cancer Surviv 6, 20–32 (2012). https://doi.org/10.1007/s11764-011-0189-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11764-011-0189-3

Keywords

Search

Navigation